Immunological changes during treatment interruptions: Risk factors and clinical sequelae

AIDS

Volumn 17, Issue 1, 2003, Pages 126-128

  Poulton, Mary B ^a   Sabin, Caroline A ^b   Fisher, Martin ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT PLANNING; VIRUS LOAD;

EID: 0037415030     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200301030-00019     Document Type: Article

References (7)

1. Mocroft A, Youle M, Moore A, Sabin CA, Madge S, Cozzi Lepri A, et al. Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS 2001; 15:185-194.
2. Taffe P, Richenbach M, Hirschel B, Opravil M, Furrer H, Janin P, et al. Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study. AIDS 2002; 16:747-755.
3. Garcia F, Plana M, Ortiz GM, Bonhoeffer S, Soriano A, Vidal C, et al. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS 2001; 15:F29- F40.
4. Sabin C, Phillips A, Fusco J, Youle M, Gill J, Barbour J, et al. The effect of treatment interruption in patients with virologic failure: results from a multi-cohort collaborative study. In: 8th Conference on Retroviruses and Opportunistic Infections. Chicago, 4-8 February 2001 [Poster no. 365].
5. Youle M, Janossy G, Turnbull W, Tilling R, Loveday C, Mocroft A, et al. Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens. AIDS 2000; 14:1717-1720.
6. Miller V, Sabin C, Hertogs K, Bloor S, Martinez-Picado J, D'Aquila R, et al. Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure. AIDS 2000; 14:2857-2867.
7. Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, et al. Virological and immunological consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viraemia. N Engl J Med 2001; 344:472-480.